Real-time enrollment status for this meningioma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:07 PM UTC
| NCT Number | NCT07428616 |
| Recruiting Status | Recruiting |
| Condition | Meningioma |
| Phase | PHASE2 |
| Target Enrollment | 100 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Exelixis |
| Last Updated on CT.gov | October 6, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT07428616 is currently recruiting participants. This phase2 study for meningioma is actively seeking new participants at 19 locations across the United States. The study is sponsored by Exelixis. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07428616 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07428616 was last updated 2 weeks ago (October 6, 2026). HelloStudys verifies this status automatically.